MARÍA PILAR
ESCRIBANO SUBÍAS
Profesora asociada de Ciencias de la Salud
Hospital Vall d'Hebron
Barcelona, EspañaPublications en collaboration avec des chercheurs de Hospital Vall d'Hebron (26)
2024
-
Risk Stratification in Pulmonary Veno-Occlusive Disease
Archivos de Bronconeumologia
2023
-
Usefulness of genetics for clinical reclassification and refinement of prognostic stratification in pulmonary arterial hypertension
Revista Espanola de Cardiologia, Vol. 76, Núm. 6, pp. 460-467
2022
-
An open-label, dose-escalation study to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of single doses of GSK2586881 in participants with pulmonary arterial hypertension
Pulmonary Circulation, Vol. 12, Núm. 1
-
Author Correction: Impact of interstitial lung disease on the survival of systemic sclerosis with pulmonary arterial hypertension (Scientific Reports, (2022), 12, 1, (5289), 10.1038/s41598-022-09353-z)
Scientific Reports
-
Clinical Implications of the Genetic Background in Pediatric Pulmonary Arterial Hypertension: Data from the Spanish REHIPED Registry
International journal of molecular sciences, Vol. 23, Núm. 18
-
Detection of azole resistance in Aspergillus fumigatus complex isolates using MALDI-TOF mass spectrometry
Clinical Microbiology and Infection, Vol. 28, Núm. 2, pp. 260-266
-
Global Emergence of Resistance to Fluconazole and Voriconazole in Candida parapsilosis in Tertiary Hospitals in Spain During the COVID-19 Pandemic
Open Forum Infectious Diseases, Vol. 9, Núm. 11
-
Impact of interstitial lung disease on the survival of systemic sclerosis with pulmonary arterial hypertension
Scientific reports, Vol. 12, Núm. 1, pp. 5289
-
Phenotypes of idiopathic pulmonary arterial hypertension
The Lancet Respiratory Medicine
2021
-
Azole and amphotericin B MIC values against aspergillus fumigatus: High agreement between spectrophotometric and visual readings using the EUCAST EDef 9.3.2 procedure
Antimicrobial Agents and Chemotherapy, Vol. 65, Núm. 1
-
Azole resistance survey on clinical Aspergillus fumigatus isolates in Spain
Clinical Microbiology and Infection, Vol. 27, Núm. 8, pp. 1170.e1-1170.e7
-
Chronic thromboembolic pulmonary hypertension in Spain: a decade of change
Revista Espanola de Cardiologia, Vol. 74, Núm. 5, pp. 384-392
-
Portopulmonary hypertension: prognosis and management in the current treatment era – results from the REHAP registry
Internal Medicine Journal, Vol. 51, Núm. 3, pp. 355-365
-
Riociguat treatment in patients with chronic thromboembolic pulmonary hypertension: Final safety data from the EXPERT registry
Respiratory Medicine, Vol. 178
2019
-
Real-life experience of inhaled iloprost for patients with pulmonary arterial hypertension: Insights from the Spanish REHAP registry
International Journal of Cardiology, Vol. 275, pp. 158-164
2018
-
Sildenafil for improving outcomes in patients with corrected valvular heart disease and persistent pulmonary hypertension: A multicenter, double-blind, randomized clinical trial
European Heart Journal, Vol. 39, Núm. 15, pp. 1255-1264
2016
-
Análisis de los genes BMPR2, TBX4 y KCNK3 y correlación genotipo-fenotipo en pacientes y familias españolas con hipertensión arterial pulmonar
Revista Espanola de Cardiologia, Vol. 69, Núm. 11, pp. 1011-1019
-
Management and outcomes in chronic thromboembolic pulmonary hypertension: From expert centers to a nationwide perspective
International Journal of Cardiology, Vol. 203, pp. 938-944
2015
-
A founder EIF2AK4 mutation causes an aggressive form of pulmonary arterial hypertension in Iberian Gypsies
Clinical Genetics, Vol. 88, Núm. 6, pp. 579-583
-
Pulmonary hypertension and congenital heart disease: An insight from the REHAP national registry
International Journal of Cardiology, Vol. 184, Núm. 1, pp. 717-723